Introduction
The endothelial barrier antigen (EBA) is a protein expressed selectively by the endothelial cells of the rat blood-brain barrier (Sternberger and Sternberger, 1987) . EBA can be detected by immunostaining tissue sections and immunoblotting brain homogenate and microvessel preparations using a monoclonal antibody (anti-EBA) (Sternberger and Sternberger, 1987; Orte et al., 1999) . Barrier vessels in the central nervous system (CNS) express EBA strongly (Sternberger and Sternberger, 1987; Sternberger et al., 1989; Perdiki et al., 1998; Ghabriel et al., 2000) . Vessels of the optic nerve and retina, both of which develop as an extension from the CNS, also express EBA strongly (Sternberger and Sternberger, 1987; Lawrenson et al., 1995a,b) . In regions of the brain known to lack a blood-brain barrier, such as the area postrema, pineal gland, median eminence and choroid plexus, the antigen is absent or expressed weakly in only some endothelial cells (Sternberger and Sternberger, 1987; Rosenstein et al., 1992) . In addition to endothelial cells of barrier vessels in the nervous system, EBA is also expressed by endothelial cells of vessels in a limited number of tissues, such as the pia mater (Sternberger and Sternberger, 1987; Rosenstein et al., 1992; Lawrenson et al., 1995a; Cassella et al., 1996 Cassella et al., , 1997 . Blood vessels in the pia mater have barrier properties and many other similarities to CNS vessels (Allt and Lawrenson, 1997) . Some endothelial cells in the spleen, and some cells in the epidermis tentatively identified as Langerhans' cells, were reported as reactive to anti-EBA (Sternberger and Sternberger, 1987) . Blood vessels in liver, heart, adrenal gland, skeletal muscle, intestine, thymus, lymph nodes, pancreas, thyroid, skin and pituitary, which do not form blood-tissue barriers, do not express the antigen (Sternberger and Sternberger, 1987) . The male reproductive system does not appear to have been investigated despite evidence for similarities between capillaries of the testis and brain (Holash et al., 1993; Stewart, 2000) .
In the testis, there is both functional and structural evidence for a blood-testis barrier (see Setchell and Waites, 1975; Setchell, 1980 Setchell, , 2001 . Much attention has been directed to the specialized junctions between pairs of adjacent Sertoli cells, which divide the cavity of the seminiferous tubule into basal and adluminal compartments (Dym and Fawcett, 1970) . The diploid, mitotically dividing spermatogonia are located in the basal compartment and, during the leptotene stage of the first meiotic prophase, the spermatocytes move into the adluminal compartment, where the rest of the process of sperm formation occurs (Dym and Cavicchia, 1977; Russell, 1977) . There is also some evidence that the peritubular myoid cells and endothelial cells of the testicular blood vessels contribute to the barrier function (Plöen and Setchell, 1992; Holash et al., 1993) . As EBA has been described as a 'barrier protein' (Sternberger and Sternberger, 1987) , it was of interest to determine whether the Sertoli cells, myoid cells
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Materials and Methods
Animals, tissues and immunocytochemistry for EBA Five adult male Sprague-Dawley rats (350-430 g) were used under ethical approval. The rats were anaesthetized by i.p. injection of sodium pentobarbitone (60 mg kg -1 ). The circulation of the rats was flushed via the heart with PBS (pH 7.4, in an atmosphere of 95% O 2 and 5% CO 2 ) for 30 s, and then with 4% (w/v) paraformaldehyde fixative in 0.1 mol phosphate buffer l -1 , pH 7.4, under constant pressure of 100 mm Hg. The testis, epididymis, spermatic cord, seminal vesicles with the associated coagulating gland, ventral prostate gland, dorsolateral prostate gland, membranous urethra, bladder-neck region and bulbourethral gland were removed. The brain, spinal cord, suprarenal gland, liver, kidney, spleen, intestine, skin, skeletal muscle and heart were removed and used as control tissues for EBA expression. Tissues were immersed in 4% (w/v) paraformaldehyde for 3 h, processed in paraffin wax, cut into sections of 5 µm and then mounted on slides coated with Silane (Sigma, St Louis, MO).
For the immunocytochemical detection of EBA, paraffin wax was removed from the tissue and endogenous peroxidase activity was blocked using 0.3% (v/v) H 2 O 2 in 70% (v/v) methanol for 30 min. After incubation for 1 h in 3% (v/v) normal horse serum (NHS), the sections were incubated overnight in anti-EBA monoclonal primary antibody (SMI 71; Sternberger Monoclonals Inc., Lutherville, MD) at a dilution of 1:3000 in 1% (v/v) NHS. Sections were incubated in a biotinylated rat-adsorbed horse anti-mouse IgG secondary antibody (Vector Lab, Burlingame, CA) diluted 1:200 in 1% (v/v) NHS followed by streptavidin-peroxidase conjugate (Rockland Inc., Gilbertsville, PA) at a dilution of 1:1000 in 1% (v/v) NHS. The peroxidase reaction product was developed by incubation for 10 min in 3,3'-diaminobenzidine tetrahydrochloride (DAB, 5 mg in 10 ml of 0.1 mol PBS l -1 , and in 30 µl 3% (v/v) H 2 O 2 ). On some slides, the glucose oxidase method was used for nickel enhancement of DAB (Shu et al., 1988) . As a negative control for immunostaining, the primary antibody was omitted on some slides. Most slides were counterstained lightly with haematoxylin.
Results

Tissue distribution of EBA
Positive immunolabelling for EBA was detected in two types of cell: endothelial cells of microvessels and epithelial cells of some accessory organs of the male reproductive system.
Strong labelling for EBA was observed in endothelial cells of most microvessels of the testis, in the tunica albuginea, in the subcapsular tissues and in the interstitial compartment in all the animals examined (Fig. 1a-b) . However, endothelial cells of lymphatic channels of the testis were not labelled (Fig. 1a) . Endothelial cells of many microvessels in the wall of vas deferens were positive for EBA (Fig.  1d) . Endothelial cells lining the artery and arterioles of the vas deferens also showed moderate immunoreactivity but large veins in the spermatic cord were not labelled (Fig. 1e) . Many microvessels among the striated muscles (Fig. 1f) and the connective tissue surrounding the membranous urethra ( Fig. 2a) showed moderate EBA labelling. A few microvessels in the seminal vesicle (Fig. 2b) , epididymis ( Fig. 2c) , coagulating gland, ventral prostate gland (Fig. 2d ) and dorsolateral prostate gland were labelled.
Labelling of epithelial cells was observed in the rete testis (Fig. 3a) . The labelling was pronounced in the sector of rete testis tubules closest to the seminiferous tubules (Fig. 3a) . Staining was not observed in the Sertoli cells or in any of the spermatogenic cells of the seminiferous tubules (Fig. 1a,b) . Apart from endothelial cells of testicular blood vessels, other cells in the interstitial compartment of the testis and the peritubular myoid cells were EBA-negative (Fig. 1a,b) . No consistent or reproducible staining was observed in epithelial cells of the epididymis or vas deferens. Examination of the accessory glands associated with the male reproductive system showed granular cytoplasmic staining for EBA. The epithelium of the dorsolateral prostate gland (Fig. 3b,c) showed strong and consistent labelling, especially in the acini next to the urethra, whereas cells in the stroma of the prostate gland were negative. The epithelium of the coagulating gland (Fig. 3d) , the ventral prostate gland (Fig. 3e ) and seminal vesicle (Fig. 3f) showed labelling in only a few epithelial cells in each tubular profile. No labelling was observed in the epithelium of the bulbourethral gland. All the positive labelling observed in cellular elements in the male reproductive tract was eliminated in control slides in which the primary antibody was omitted from the staining protocol (Fig. 4a) . Control sections stained with haematoxylin and eosin for general histology did not show any similar brown deposits in epithelial or endothelial cells. Examination of other tissues including the intestine (Fig. 4b) , skin of the footpad, liver, kidney, adrenal cortex, skeletal muscle and cardiac muscle did not show any labelling for EBA. The brain and spinal cord (Fig. 4c) used as a positive control for EBA staining showed strong labelling of vessels throughout the grey and white matter. The spleen showed labelling of some endothelial cells of sinusoids in the red pulp (Fig. 4d) . However, the central arterioles of the white pulp (Fig. 4d) and the splenic artery and vein at the hilum were not labelled. All the above findings were consistent in the five animals examined and were reproducible in several staining sessions.
Discussion
In the testis, there appears to be a barrier between the blood and the fluid in the lumina of the seminiferous tubules. Evidence for this barrier includes the uneven colouration of the testis after injection of certain dyes and the distribution of some radioactive markers determined by autoradiography or by comparing their volumes of distribution with morphological estimates of the volumes of the various compartments of the testis. There are also differences in composition between the blood plasma and testicular lymph, and the fluid in the lumina of the seminiferous tubules and the rete testis. In addition, various markers pass from the bloodstream into these testicular fluids at different rates (for reviews, see Setchell and Waites, 1975; Setchell, 1980; Setchell et al., 1994) . Morphologically, attention has been focused on the specialized junctions between pairs of adjacent Sertoli cells in the tubules, which block the entry into the tubules of electron-opaque markers, such as lanthanum and horseradish peroxidase (Dym and Fawcett, 1970) . In the present study, Sertoli cells did not show staining for EBA. In the brain, the barrier to the tracers is established in late gestation (Olsson et al., 1968) and EBA can be detected a few days after birth (Rosenstein et al., 1992; Cassella et al., 1996) . EBA appears to play an important role in the blood-brain barrier, as injection of anti-EBA antibody causes opening of the blood-brain barrier (Ghabriel et al., 2000) . The barrier function of Sertoli cells may be dependent on unknown regulatory factors, which are different from those that control barrier properties of brain endothelial cells. In the testis, the barrier to dyes and the specialized junctions between Sertoli cells develop only at puberty (Kormano, 1967; Russell et al., 1989) , and the barrier becomes less effective outside the breeding season in seasonally breeding mammals. Although the barrier in the testis and spermatogenesis are both disrupted under some circumstances (vitamin A deficiency, disorganization of the microtubules in the Sertoli cell, after efferent duct ligation or injections of cadmium salts and in very old rats), spermatogenesis can be disrupted in other ways without the barrier being affected (for a review, see Setchell, 2001 ). In addition to the Sertoli cells, other cells in the testis, such as the endothelial cells of testicular blood vessels (Holash et al., 1993) and peritubular myoid cells (Fawcett et al., 1970) , may also contribute to the barrier function. A partial barrier function of peritubular myoid cells was indicated from ultrastructural studies showing a clear peritubular space deep to the myoid cells in contrast to the interstitial tissue, which showed proteinaceous content. These cells are also able to exclude large molecular tracers, such as thorium dioxide and carbon, but allow entry of smaller tracers, such as ferritin and peroxidase (Fawcett et al., 1970) . The peritubular myoid cells are joined by tight junctions, although 10-15% of the junctions appear to have gaps of 20 nm (Dym and Fawcett, 1970) . These myoid cells also contain a specific transport system for urea (Fenton et al., 2000) . However, in the present study no staining for EBA was noted in the peritubular myoid cells.
Endothelial cells of testicular microvessels share several features with those in the brain. There is a specific saturable transport system for leucine in endothelial cells of the testis and the kinetic properties of this system are very similar to those found in the brain (Bustamante and Setchell, 2000) . Endothelial cells in the testis contain the glucose transporter GLUT-1, gamma glutamyl transpeptidase and the multidrug resistance gene product P-glycoprotein (Harik et al., 1990; Holash et al., 1993) , which was thought to be specific to the brain. Testicular expression of EBA, as observed in the present study, provides further support for the similarities between brain and testicular blood vessels. It has also been demonstrated that the Leydig cells, which lie close to the endothelial cells in the testis, contain S-100 protein, the glial fibrillary acidic protein and glutamine synthetase (Holash et al., 1993) . These are characteristic markers of astrocytes, the cells in the brain that may confer the barrier properties on brain endothelial cells (Risau, 1991) .
Although the results discussed above indicate that testicular blood vessels share many biochemical markers with brain vessels, there are some differences. Unlike brain vessels, those of the testis do not express the transferrin receptor (Holash et al., 1993) . Although endothelial cells of the brain and testis express the P-glycoprotein, the distribution of this marker is different in the two systems. Pglycoprotein is localized to luminal membranes in brain endothelial cells but to luminal and abluminal membranes in testicular endothelial cells (Stewart et al., 1996) . The biological significance of the difference in the distribution of P-glycoprotein in the two systems is not understood (Stewart et al., 1996) . In addition, morphological and physiological studies showed some differences between the two vascular beds. Albumin, which does not freely enter the brain, is readily detectable in the testicular lymph (for a review, see Setchell and Waites, 1975) . Testicular capillaries are continuous and have intercellular tight junctions (Weihe et al., 1979) , but the density of these junctions is lower than that of brain endothelial cells (Holash et al., 1993; Stewart, 2000) . Testicular capillaries are larger and have a thicker wall and a higher density of mitochondria than that of brain capillaries (Holash et al., 1993; Stewart, 2000) . Other studies have provided evidence for leakage of Evans blue (Caster et al., 1955) and trypan blue (Kormano, 1968) into the interstitial tissues of the testis. Horseradish peroxidase can also enter the interstitial tissues of the testis (Weihe et al., 1979) , but cannot enter the brain (Brightman and Reese, 1969) . The difference in permeability between testicular and brain blood vessels may be due to differences in the structure and function of the tight junctions between endothelial cells in the two systems. Brain blood vessels have long sinuous intercellular junctions with high electrical resistance. Testicular blood vessels have wide compartments between the series of tight junctional appositions and some intercellular junctions are expanded (> 10 nm), indicating patent junctions (Fawcett et al., 1970; Holash et al., 1993; Stewart, 2000) . Fifteen per cent of testicular blood vessels have wide junctions with a higher cleft index (Holash et al., 1993) , which may explain their higher permeability compared with brain vessels. Nevertheless, in the present study, strong EBA labelling was observed in the majority of testicular vessels.
In the current study, strong and consistent labelling with anti-EBA was observed in the epithelium of the dorsolateral prostate gland, and in a few epithelial cells of the coagulating gland, the ventral prostate gland and the seminal vesicles. It is possible that anti-EBA may be crossreacting with tissue components or labelling a related protein.
However, high specificity of anti-EBA (Sternberger and Sternberger, 1987 ) makes this unlikely. The prostatic epithelium has tight junctions and barrier properties (Kachar and Reese, 1983) . However, it is unlikely that EBA expression is directly related to the tight junctions in prostatic epithelium as: (i) it is not expressed in epithelia with tight junctions in other body organs; and (ii) in brain endothelial cells, EBA is not associated with intercellular junctions, but is expressed on the luminal membrane (Rosenstein et al., 1992; Lawrenson et al., 1995a; Zhu et al., 2001 ). In the prostate, EBA was present predominantly in the apical cytoplasm, which suggests its secretion into the fluids of associated glands. Thus, EBA in this accessory gland may have an unknown function in relation to survival or motility of spermatozoa. The secretions of the male reproductive accessory glands vary widely in function and chemical composition in different species (for a review, see Setchell et al., 1994) . In rats, diversity in chemical composition occurs among the secretions of the various reproductive accessory glands. The prostatic secretion contains inositol, polyamines and epidermal growth factor (Jacobs and Story, 1988) . A 22 kDa protein has also been detected in the rat ventral prostate gland (Carmo-Fonseca and Vaz, 1989) . Anti-EBA reacts with immunoblots of rat brain microvessel membranes and shows three positive bands of 30, 25 and 23.5 kDa proteins (Sternberger and Sternberger, 1987) . Whether the 22 kDa prostatic protein is related to the 23.5 kDa band of brain preparations is yet to be determined. However, immunofluorescence showed that the 22 kDa protein is expressed only in the ventral prostate gland and not in the dorsolateral prostate gland (Carmo-Fonseca and Vaz, 1989) , which in the present study showed the strongest immunoreactivity to anti-EBA, whereas only a few epithelial cells were positive for EBA in the ventral prostate gland. Preliminary observations in our laboratory using PAGE and immunoblotting indicate that proteins of similar molecular masses in the brain, testis and prostate gland are reacting with anti-EBA.
In the current study, epithelial cells of the coagulating gland also showed labelling for EBA. The coagulating gland is considered as the anterior lobe of the prostate gland, although anatomically it is closely apposed to the seminal vesicle. Its secretion may have a similar function to that of the main prostate gland. However, the presence of only a few EBA-positive cells in the seminal vesicle may reflect a difference in function between the fluids secreted by the seminal vesicle and the coagulating gland. Seminal vesicle fluid contains a substrate (SVSII) for enzymes secreted by the coagulating gland to form the copulatory plug (Setchell et al., 1994) . Seminal vesicle proteins bind to sperm membrane, and may have an effect on the spermatozoa while the binding is regulated by other proteins in the ejaculate secreted by the coagulating gland (Carballada and Esponda, 1998) . EBA labelling of the rete testis epithelium reported in the current study may also be related to a specific unknown function of the luminal fluid.
